Search

everythinglearnresearchcommunity

for

Search:↓

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

No single treatment is consistently effective for alopecia areata, and more research is needed.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.